Staging prostate cancer

Microscopy Research and Technique

Volumn 51, Issue 5, 2000, Pages 423-429

  Hoedemaeker, Robert F ^a,b   Vis, André N ^a   Van Der Kwast, Theodorus H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Neoplasm staging; Prostate cancer; Prostatic neoplasms

Indexed keywords

DISEASES; PATIENT TREATMENT; UROLOGY;

'CURRENT; AFTER-TREATMENT; CLINICAL EVALUATION; CLINICAL TOOLS; CURRENT SITUATION; LYMPH NODE; MULTIFOCAL; NEOPLASM STAGING; PROSTATE CANCERS; PROSTATIC NEOPLASMS;

TUMORS;

ARTICLE; BLADDER NECK; CANCER STAGING; CLINICAL EXAMINATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE;

EID: 0034565150     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20001201)51:5<423::AID-JEMT4>3.0.CO;2-4     Document Type: Article

References (40)

1. Belville WD. 1995. Are T1c tumors different from incidental tumors found at autopsy? The risk and reality of overdetection. Semin Urol Oncol 13:181-186.
2. Bostwick DG, Elbe JN. (eds.) 1997. Urologic surgical pathology. Rochester: Mosby.
3. Bostwick DG, Myers RP, Oesterling JE. 1994. Staging of prostate cancer. Semin Surg Oncol 10:60-72.
4. British Association of Urological Surgeons: TNM subcommittee. 1995. The TNM classification of prostate cancer: a discussion of the 1992 classification. Br J Urol 76:279-285.
5. Cohen MB, Soloway MS, Murphy WM. 1994. Sampling of radical prostatectomy specimens. How much is adequate? Am J Clin Pathol 101:250-252.
6. Collins WE. 1975. TNM classification of malignant tumours of the bladder, prostate, testis and kidney. Can J Surg 18:468-475.
7. Com BW, Hanks GE, Lee WR, Schultheiss T. 1995. Do the current subclassifications of stage T3 adenocarcinoma of the prostate have clinical relevance? Urology 45:484-489.
8. Djavan B, Susani M, Bursa B, Basharkhah A, Simak R, Marberger M. 1999. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. Tech Urol 5:139-142.
9. Epstein JI, Carmichael M, Partin AW, Walsh PC. 1993. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 149:1478-1481.
10. Epstein JI, Walsh PC, Carmichael M, Brendler CB. 1994. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. Jama 271:368-374.
11. Franks LM. 1954. Latent carcinoma of the prostate. J Path Bact 68:603-616.
12. Goto Y, Ohori M, Arakawa A, Kattan MW, Wheeler TM, Scardino PT. 1996. Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 156:1059-1063.
13. Hall GS, Kramer CE, Epstein JI. 1992. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol 16:315-324.
14. Hoedemaeker RF, Rietbergen JBW, Kranse R, van der Kwast TH, Schröder FH. 1998a. Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer. World J Urol 15:339-345.
15. Hoedemaeker RF, Ruijter ETG, Ruizeveld de Winter JA, Van der Kaa CA, Van der Kwast TH. 1998b. Processing radical prostatectomy specimens: A comprehensive and standardized protocol. J Urol Pathol 9:211-222.
16. Hoedemaeker RF, Rietbergen JB, Kranse R, Schroder FH, van der Kwast ThH. 2000. Histopathological prostate cancer characteristics at radical prostatectomy after population based screening. J Urol 164:411-415.
17. Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA. 1989. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol 141:1091-1094.
18. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. 1990. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol 14:240-247.
19. Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR. 1998. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83:1679-1684.
20. Oesterling JE, Suman VJ, Zincke H, Bostwick DG. 1993. PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors. Urol Clin North Am 20:687-693.
21. Ohori M, Wheeler TM, Dunn JK, Stamey TA, Scardino PT. 1994a. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 152:1714-1720.
22. Ohori M, Wheeler TM, Scardino PT. 1994b. The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer 74:104-114.
23. Ravery V, Chastang C, Toublanc M, Boccon-Gibod L, Delmas V. 2000. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur Urol 37:449-455.
24. Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ. 1996. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol 180:295-299.
25. Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ, Haas GP. 1994. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 8:439-443.
26. Sakr WA, Grignon DJ, Visscher DW, Wolman SR, Crissman JD. 1995. Evaluating the radical prostatectomy specimen, part I. J Urol Pathol 3:355-364.
27. Sattar AA, Noel JC, Vanderhaeghen JJ, Schulman CC, Wespes E. 1995. Prostate capsule: computerized morphometric analysis of its components. Urology 46:178-181.
28. Scaletscky R, Koch MO, Eckstein CW, Bicknell SL, Gray GF Jr, Smith JA Jr. 1994. Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen. J Urol 152:129-1231.
29. Schmid HP, McNeal JE. 1992. An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16:184-191.
30. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. 1992. The TNM classification of prostate cancer. Prostate Suppl 4:129-138.
31. Smith JA Jr. 1995. Stage T1c prostate cancer: perspectives on clinical management. Sem Urol Oncol 13:238-244.
32. Soh S, Kattan MW, Berkman S, Wheeler TM, Scardino PT. 1997. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol 157:2212-2218.
33. Stephenson RA, Stanford JL. 1997. Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen. World J Urol 15:331-335.
34. Stormont TJ, Farrow GM, Myers RP, Blute ML, Zincke H, Wilson TM, Oesterling JE. 1993. Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration. Urology 41:3-8.
35. Theiss M, Wirth MP, Manseck A, Frohmuller HG. 1995. Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy. Prostate 27:13-17.
36. Villers AA, McNeal JE, Redwine EA, Freiha FS, Stamey TA. 1990. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol 143:1183-1187.
37. Visser O, Coebergh JWW, Schouten LJ, van Dijck JAAM. 1998. Incidence of cancer in the Netherlands 1995; Seventh report of the Netherlands cancer registry. Utrecht: Vereniging van Integrale Kankercentra.
38. Wheeler TM, Dillioglugil O, Kattan MW, Arakawa A, Soh S, Suyama K, Ohori M, Scardino PT. 1998. Clinical and pathological signifigance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol 29:856-862.
39. Zagars GK, Geara FB, Pollack A, von Eschenbach AC. 1994. The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy. Cancer 73:1904-1912.
40. Zietman AL, Edelstein RA, Coen JJ, Babayan RK, Krane RJ. 1994. Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology 43:828-833.